- Home
- CHR vs BOLT Comparison
CHR vs BOLT Comparison
Compare CHR & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHR
- BOLT
- Stock Information
- Founded
- CHR 2016
- BOLT 2015
- Country
- CHR China
- BOLT United States
- Employees
- CHR N/A
- BOLT N/A
- Industry
- CHR EDP Services
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- CHR Technology
- BOLT Health Care
- Exchange
- CHR Nasdaq
- BOLT Nasdaq
- Market Cap
- CHR 24.4M
- BOLT 25.3M
- IPO Year
- CHR N/A
- BOLT 2021
- Fundamental
- Price
- CHR $2.67
- BOLT $0.62
- Analyst Decision
- CHR
- BOLT Hold
- Analyst Count
- CHR 0
- BOLT 5
- Target Price
- CHR N/A
- BOLT $1.25
- AVG Volume (30 Days)
- CHR 6.4K
- BOLT 113.4K
- Earning Date
- CHR 07-31-2024
- BOLT 11-12-2024
- Dividend Yield
- CHR N/A
- BOLT N/A
- EPS Growth
- CHR N/A
- BOLT N/A
- EPS
- CHR 3.44
- BOLT N/A
- Revenue
- CHR $155,947,000.00
- BOLT $9,779,000.00
- Revenue This Year
- CHR N/A
- BOLT $16.30
- Revenue Next Year
- CHR N/A
- BOLT N/A
- P/E Ratio
- CHR $0.79
- BOLT N/A
- Revenue Growth
- CHR 0.88
- BOLT 35.86
- 52 Week Low
- CHR $2.18
- BOLT $0.55
- 52 Week High
- CHR $3.90
- BOLT $1.56
- Technical
- Relative Strength Index (RSI)
- CHR 45.02
- BOLT 43.06
- Support Level
- CHR $2.67
- BOLT $0.61
- Resistance Level
- CHR $2.86
- BOLT $0.69
- Average True Range (ATR)
- CHR 0.10
- BOLT 0.03
- MACD
- CHR -0.03
- BOLT -0.00
- Stochastic Oscillator
- CHR 28.57
- BOLT 16.67
About CHR Cheer Holding Inc.
Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerReal, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.